285 related articles for article (PubMed ID: 31387554)
1. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
[TBL] [Abstract][Full Text] [Related]
2. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
[TBL] [Abstract][Full Text] [Related]
3. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
[TBL] [Abstract][Full Text] [Related]
4. Rosmarinic Acid Methyl Ester Regulates Ovarian Cancer Cell Migration and Reverses Cisplatin Resistance by Inhibiting the Expression of Forkhead Box M1.
Lim SH; Nam KH; Kim K; Yi SA; Lee J; Han JW
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33053721
[TBL] [Abstract][Full Text] [Related]
5. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
[TBL] [Abstract][Full Text] [Related]
6. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer.
Leisching GR; Loos B; Botha MH; Engelbrecht AM
Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060
[TBL] [Abstract][Full Text] [Related]
7. Constituents of Mediterranean Spices Counteracting Vascular Smooth Muscle Cell Proliferation: Identification and Characterization of Rosmarinic Acid Methyl Ester as a Novel Inhibitor.
Liu R; Heiss EH; Waltenberger B; Blažević T; Schachner D; Jiang B; Krystof V; Liu W; Schwaiger S; Peña-Rodríguez LM; Breuss JM; Stuppner H; Dirsch VM; Atanasov AG
Mol Nutr Food Res; 2018 Apr; 62(7):e1700860. PubMed ID: 29405576
[TBL] [Abstract][Full Text] [Related]
8. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
9. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway.
Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X
Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839
[TBL] [Abstract][Full Text] [Related]
10. Rosmarinic Acid Methyl Ester Inhibits LPS-Induced NO Production via Suppression of MyD88- Dependent and -Independent Pathways and Induction of HO-1 in RAW 264.7 Cells.
So Y; Lee SY; Han AR; Kim JB; Jeong HG; Jin CH
Molecules; 2016 Aug; 21(8):. PubMed ID: 27548124
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation.
Xu X; Sun J; Song R; Doscas ME; Williamson AJ; Zhou J; Sun J; Jiao X; Liu X; Li Y
Oncotarget; 2017 May; 8(18):30438-30454. PubMed ID: 28389629
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin.
Dhar R; Basu A
Int J Oncol; 2008 May; 32(5):1133-7. PubMed ID: 18425342
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.
Huang L; Chen J; Quan J; Xiang D
Bioengineered; 2021 Dec; 12(1):3065-3076. PubMed ID: 34224305
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells.
Wu CF; Hong C; Klauck SM; Lin YL; Efferth T
J Ethnopharmacol; 2015 Dec; 176():55-68. PubMed ID: 26476154
[TBL] [Abstract][Full Text] [Related]
16. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway.
Liao XZ; Gao Y; Sun LL; Liu JH; Chen HR; Yu L; Chen ZZ; Chen WH; Lin LZ
Phytother Res; 2020 May; 34(5):1142-1153. PubMed ID: 31985119
[TBL] [Abstract][Full Text] [Related]
17. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway.
Jiang S; Chang H; Deng S; Fan D
Int J Oncol; 2019 Jun; 54(6):1933-1942. PubMed ID: 31081049
[TBL] [Abstract][Full Text] [Related]
18. Combination of pharmacophore hypothesis, genetic function approximation model, and molecular docking to identify novel inhibitors of S6K1.
Zhang H; Xiang ML; Liang JY; Zeng T; Zhang XN; Zhang J; Yang SY
Mol Divers; 2013 Nov; 17(4):767-72. PubMed ID: 23982212
[TBL] [Abstract][Full Text] [Related]
19. The cytotoxic concentration of rosmarinic acid increases MG132-induced cytotoxicity, proteasome inhibition, autophagy, cellular stresses, and apoptosis in HepG2 cells.
Ozgun GS; Ozgun E
Hum Exp Toxicol; 2020 Apr; 39(4):514-523. PubMed ID: 31876192
[TBL] [Abstract][Full Text] [Related]
20. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
